InvestorsHub Logo
Followers 2
Posts 625
Boards Moderated 0
Alias Born 07/10/2009

Re: None

Wednesday, 04/25/2018 5:10:23 PM

Wednesday, April 25, 2018 5:10:23 PM

Post# of 19499
Apparently Bracco doesn't like competition.

Bracco hits Jubilant with patent complaint on rubidium PET
By Wayne Forrest, AuntMinnie.com staff writer

April 6, 2018 -- Contrast developer Bracco Diagnostics has filed a complaint against radiopharmaceutical firm Jubilant DraxImage and two of its affiliates for alleged patent infringement regarding rubidium-based radiopharmaceuticals for cardiac PET studies.
Bracco filed papers on March 27 with the U.S. International Trade Commission (ITC), asking that the ITC issue an order to stop Jubilant from importing its Ruby-Fill rubidium-82 generators and related products and components.

Bracco is also asking for a cease-and-desist order that would prohibit the sale of Jubilant's Ruby elution system and Ruby-Fill generators that have already been imported, as well as damages and injunctive relief. Jubilant Pharma and Jubiliant Life Sciences are included in the litigation.

Bracco has also filed suit against Jubilant in the U.S. District Court for the District of New Jersey with charges similar to the ITC complaint. Bracco's patents relate to strontium-rubidium radioisotope infusion systems, according to a letter Bracco sent to customers on March 27.

"Bracco welcomes fair competition in the marketplace, but it is imperative that competitors respect the patent rights of others," wrote Bracco Vice President and General Counsel Vito DeBari.

In the letter, DeBari claims that Bracco is the "pioneer" in rubidium-82 generators and has "invested significantly" in the development and advancement of rubidium-82 infusion systems. The company said it intends to protect its investments with the complaint and lawsuit.

In a written response, Jubilant said that it has "carefully reviewed" Bracco's allegations and intends to "vigorously defend" its legal positions.

"We are very confident that ultimately Jubilant DraxImage will be successful in this litigation and do not expect the litigation to affect the continuing availability of Ruby-Fill products in the U.S. or elsewhere," the company added.

The Ruby elution system and the proprietary Ruby consumable accessories are used only with the Ruby-Fill rubidium-82 generator for PET imaging of the myocardium and manufactured only by Jubilant DraxImage, according to the company. Both devices are available throughout the U.S.

Bracco's CardioGen-82 generator produces rubidium chloride for myocardial PET imaging under rest and pharmacological stress in adult patients with suspected or existing coronary artery disease.

The Ruby-Fill generator received clearance from the U.S. Food and Drug Administration (FDA) in September 2016 and was first available in the U.S. in May 2017. The device is also available in Canada and Switzerland.

Bracco had not approached Jubilant DraxImage about its concerns regarding possible patent infringement issues, said Sarah Marquis, director of legal affairs for Jubilant DraxImage.

https://www.auntminnie.com/index.aspx?sec=sup&sub=mol&pag=dis&ItemID=120437